Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Withdrawn × Hearing Loss × Clear all

Phase

Phase NA 1 Phase 1 1

Status

Completed 3 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 48 Breast Neoplasms 45 Carcinoma, Non-Small-Cell Lung 36 Leukemia, Myeloid, Acute 32 Lymphoma 30 Pancreatic Neoplasms 28 Leukemia 27 Leukemia, Lymphocytic, Chronic, B-Cell 26 Ovarian Neoplasms 24 Precursor Cell Lymphoblastic Leukemia-Lymphoma 23 Multiple Myeloma 23 Lymphoma, Non-Hodgkin 23 Recurrence 20 Neoplasm Metastasis 20 Lymphoma, Large B-Cell, Diffuse 19 Lung Neoplasms 19 Glioblastoma 19 Brain Neoplasms 19 Melanoma 18 Prostatic Neoplasms 16 Colorectal Neoplasms 16 Squamous Cell Carcinoma of Head and Neck 14 Lymphoma, Follicular 14 Sarcoma 13 Lymphoma, Mantle-Cell 13 Lymphoma, B-Cell 12 Urinary Bladder Neoplasms 11 Lymphoma, B-Cell, Marginal Zone 11 Carcinoma, Hepatocellular 11 Uterine Cervical Neoplasms 10

Interventions

Saline Solution 1 Ringer's Lactate 1 Ofloxacin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00584155 2015-05-27

Protection From Cisplatin Ototoxicity by Lactated Ringers

University of Oklahoma

Phase 1 Withdrawn

Ear Neoplasms, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡